[go: up one dir, main page]

Raychoudhuri et al., 2011 - Google Patents

ISG56 and IFITM1 proteins inhibit hepatitis C virus replication

Raychoudhuri et al., 2011

View PDF @Full View
Document ID
2136277114009188637
Author
Raychoudhuri A
Shrivastava S
Steele R
Kim H
Ray R
Ray R
Publication year
Publication venue
Journal of virology

External Links

Snippet

Hepatitis C virus (HCV) often leads to persistent infection. Interferon (IFN) and IFN- stimulated genes (ISGs) are amplified during HCV infection but fail to eliminate virus from the liver in a large number of infected patients. We have observed previously that HCV …
Continue reading at journals.asm.org (PDF) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/576Immunoassay; Biospecific binding assay for hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis

Similar Documents

Publication Publication Date Title
Raychoudhuri et al. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication
Dukhovny et al. A CRISPR activation screen identifies genes that protect against Zika virus infection
Ashour et al. NS5 of dengue virus mediates STAT2 binding and degradation
Son et al. Double-stranded RNA is detected by immunofluorescence analysis in RNA and DNA virus infections, including those by negative-stranded RNA viruses
Kumthip et al. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling
Bhanja Chowdhury et al. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A
Yamamoto et al. Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay
Xiao et al. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm
Chen et al. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment
Jones et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression
Suzuki et al. Characterization of RyDEN (C19orf66) as an interferon-stimulated cellular inhibitor against dengue virus replication
Pattabhi et al. Targeting innate immunity for antiviral therapy through small molecule agonists of the RLR pathway
Todt et al. Antiviral activities of different interferon types and subtypes against hepatitis E virus replication
Yu et al. Hepatitis B virus polymerase inhibits RIG-I-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKϵ and DDX3
Lokugamage et al. Middle East respiratory syndrome coronavirus nsp1 inhibits host gene expression by selectively targeting mRNAs transcribed in the nucleus while sparing mRNAs of cytoplasmic origin
Wang et al. Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells
Spiegel et al. Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3
Ambrose et al. West Nile virus differentially modulates the unfolded protein response to facilitate replication and immune evasion
Ikegame et al. Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells
Boudreau et al. Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor β-dependent manner: a new contributor to HCV-induced oxidative stress
Lu et al. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1
Kanazawa et al. Regulation of hepatitis C virus replication by interferon regulatory factor 1
Arita et al. Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection
Xue et al. ISG12a restricts hepatitis C virus infection through the ubiquitination-dependent degradation pathway
Bedard et al. Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses